Search results
Very good news for Geron stock price: now what? | Invezz
Invezz· 7 days agoGeron Corporation (NASDAQ: GERN) stock price went vertical on Friday as investors cheered the latest...
Geron surges after winning first US FDA approval for blood disorder drug
Colorado Springs Gazette· 7 days agoThe health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes (MDS), a ...
Hypertrophic Cardiomyopathy 101: What every student-athlete should know
The Journal Times· 4 days agoHeart conditions may be more often associated with older individuals, but you might be surprised to...
Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
FierceBiotech· 4 days agoNot content with bringing in one of the largest private biotech fundraises of 2024 so far, Alumis...
Long Island City biotech raises $25M Series B to develop gene therapies
Crain's New York Business· 6 days agoExisting investors Third Kind Venture Capital, Red Cell Partners and Empire State Development participated in the funding round. Bristol Myers Squibb also participated as a new investor following ...
Once-Weekly Somapacitan Remains Safe, Effective Long-Term
Medscape· 7 days agoGrowth improvements were similar between children taking somapacitan for 3 years and those who...
Hypertrophic Cardiomyopathy 101: What every student-athlete should know
Wisconsin State Journal· 4 days agoHeart conditions may be more often associated with older individuals, but you might be surprised to...
Dynamic Troponin Changes Unreliable for MI in Acute Stroke
Medscape· 7 days agoIn acute ischemic stroke, high baseline, high-sensitivity cardiac troponin values are a better indicator of myocardial infarction than dynamic changes in troponin levels, new data suggested.
State Drug Pricing Boards Forge Ahead With Eyes on Amgen Suit
Bloomberg Law· 4 days agoState affordability boards seeking to limit what health plans pay for prescription drugs are confident they will withstand legal challenges as Colorado battles what’s expected to be the first ...
Geron surges after winning first US FDA approval for blood disorder drug
AOL· 7 days ago(Reuters) -Shares of Geron surged more than 20% on Friday, a day after the company gained its first approval from the U.S. Food and Drug Administration for its blood disorder drug. The health ...